Targeting Macular Pigment in Intermediate Age-Related Macular Degeneration: Oral Supplementation Versus Transscleral Iontophoresis in a Prospective Pilot Study.

J Clin Med · 2026 · PMC13164182 · PMID 42122923

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the between-group difference in MPOD change did not reach statistical significance, a moderate effect size was observed, suggesting a potentially clinically meaningful difference in favor of iontophoresis.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.